Literature DB >> 23663164

Pathogenesis of Crimean-Congo hemorrhagic fever.

Esragül Akıncı1, Hürrem Bodur, Hakan Leblebicioglu.   

Abstract

Although Crimean-Congo hemorrhagic fever (CCHF) is a widespread tick-borne disease, little is known about its pathogenesis. The interaction of the virus with host cells is most likely responsible for the pathogenesis of CCHF. The main contributors are endothelial cells (ECs) and immune cells. There are 2 theories underlying the CCHF pathogenesis: One is that the virus interacts with the ECs directly and the other that it interacts indirectly via immune cells with subsequent release of soluble mediators. ECs are activated upon infection by the upregulation of soluble molecules and proinflammatory cytokines. Probably, in severe cases, deregulation and excessive release of the cytokines accompanied by endothelial activation have toxic effects, leading to increased vascular permeability, vasodilatation, and subsequently hypotension, multiple organ failure, shock, and death. Studies indicate that CCHF virus (CCHFV) also can impair the innate immune system and cause a delay in adaptive immune response, which is critical for the clearance of CCHFV. The virus has many different ways to block the immune response, leading to uncontrolled viral replication followed by systemic spread of the virus throughout the body. Partial activation of dendritic cells and macrophages, delayed induction of interferons, weak antibody response, apoptosis of lymphocytes, and hemophagocytosis are some of these tactics. However, there are many points waiting for clarification about the pathogenesis of CCHF. Although the high risk of contagiousness limits research, we need more studies to understand the CCHF pathogenesis better. Here we review the main characteristics of the pathogenesis of CCHF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23663164     DOI: 10.1089/vbz.2012.1061

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  23 in total

1.  Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever.

Authors:  Elif Bilge Uysal; Enver Sancakdar; Ayşe Şeker; Köksal Deveci; Nevin Tuzcu; Hekim Karapınar
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever.

Authors:  Ayse Erturk; Erkan Cure; Emine Parlak; Medine Cumhur Cure; Suleyman Yuce; Bayram Kizilkaya
Journal:  Int J Clin Exp Med       Date:  2014-10-15

3.  Virus-Derived DNA Forms Mediate the Persistent Infection of Tick Cells by Hazara Virus and Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Maria Vittoria Salvati; Claudio Salaris; Vanessa Monteil; Claudia Del Vecchio; Giorgio Palù; Cristina Parolin; Arianna Calistri; Lesley Bell-Sakyi; Ali Mirazimi; Cristiano Salata
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

4.  Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone.

Authors:  Hana Rohan
Journal:  PLoS Negl Trop Dis       Date:  2022-05-19

5.  Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever.

Authors:  Safak Kaya; Nazif Elaldi; Ayhan Kubar; Nevcihan Gursoy; Meral Yilmaz; Gulderen Karakus; Turabi Gunes; Zubeyde Polat; Mustafa Gokhan Gozel; Aynur Engin; Ilyas Dokmetas; Mehmet Bakir; Neziha Yilmaz; Mehmet Sencan
Journal:  BMC Infect Dis       Date:  2014-07-28       Impact factor: 3.090

6.  Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever.

Authors:  Nil Guler; Cafer Eroglu; Hava Yilmaz; Adil Karadag; Hasan Alacam; Mustafa Sunbul; Tom E Fletcher; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 7.  Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions.

Authors:  Anna Papa; Katerina Tsergouli; Katerina Tsioka; Ali Mirazimi
Journal:  Front Cell Infect Microbiol       Date:  2017-05-26       Impact factor: 5.293

8.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

9.  Serum β-Defensin-2 Levels and Their Relationship with the Clinical Course and Prognosis in Patients with Crimean-Congo Hemorrhagic Fever.

Authors:  Osman Aksoy; Emine Parlak; Mehmet Parlak; Hülya Aksoy
Journal:  Med Princ Pract       Date:  2015-11-05       Impact factor: 1.927

10.  Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.

Authors:  Tom E Fletcher; Abuova Gulzhan; Salih Ahmeti; Seif S Al-Abri; Zahide Asik; Aynur Atilla; Nick J Beeching; Heval Bilek; Ilkay Bozkurt; Iva Christova; Fazilet Duygu; Saban Esen; Arjun Khanna; Çiğdem Kader; Masoud Mardani; Faisal Mahmood; Nana Mamuchishvili; Natalia Pshenichnaya; Mustafa Sunbul; Tuğba Y Yalcin; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.